Vigabatrin therapy in six patients with succinic semialdehyde dehydrogenase deficiency
- 1 March 1995
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 18 (2) , 143-146
- https://doi.org/10.1007/bf00711750
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Enzymatic and immunological demonstration of normal and defective succinic semialdehyde dehydrogenase activity in fetal brain, liver and kidneyJournal of Inherited Metabolic Disease, 1993
- 4‐Hydroxybutyric aciduria: Clinical findings and vigabatrin therapyJournal of Inherited Metabolic Disease, 1993
- Stable isotope dilution analysis of GABA in CSF using simple solvent extraction and electron‐capture negative‐ion mass fragmentographyJournal of Inherited Metabolic Disease, 1993
- Further evaluation of Vigabatrin therapy in 4-hydroxybutyric aciduriaEuropean Journal of Pediatrics, 1992
- 4-Hydroxybutyric aciduria: Application of a fluorometric assay to the determination of succinic semialdehyde dehydrogenase activity in extracts of cultured human lymphoblastsClinica Chimica Acta; International Journal of Clinical Chemistry, 1991
- Stable isotope dilution analysis of 4-hydroxybutyric acid: An accurate method for quantification in physiological fluids and the prenatal diagnosis of 4-hydroxybutyric aciduriaJournal of Mass Spectrometry, 1990
- VIGABATRIN THERAPY IN PATIENT WITH SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCYThe Lancet, 1989
- VIGABATRIN IN GABA METABOLISM DISORDERSThe Lancet, 1989